<DOC>
	<DOCNO>NCT02680158</DOCNO>
	<brief_summary>The purpose study compare acute tear production produce Oculeve Intranasal Lacrimal Neurostimulator two control device participant aqueous tear deficiency .</brief_summary>
	<brief_title>1-Day Study Evaluate Safety Effectiveness Intranasal Lacrimal Neurostimulator</brief_title>
	<detailed_description>This prospective , randomize , control , double-masked , multicenter clinical trial subject aqueous tear deficiency receive three different device application randomize sequence .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<criteria>Subjects aqueous tear deficiency Literate , able speak English Spanish , able complete questionnaire independently Willing sign inform consent deem capable complying requirement study protocol Chronic recurrent epistaxis , coagulation disorder condition , opinion investigator , may lead clinically significant increase bleed Nasal sinus surgery include nasal cautery significant trauma Cardiac demand pacemaker , implanted defibrillator implant electronic device Diagnosis epilepsy Corneal transplant either eyes Participation clinical trial new active substance new device within 30 day Screening Visit A woman pregnant , plan pregnancy , nurse Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>